Stock VNDA VANDA PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Vanda Pharmaceuticals Inc.

Equities

VNDA

US9216591084

Market Closed - Nasdaq
Other stock markets
 21:00:00 13/09/2024 BST 		5-day change 1st Jan Change
5.100 USD +2.20% Intraday chart for Vanda Pharmaceuticals Inc. +0.39% +20.85%
07-31 Transcript : Vanda Pharmaceuticals Inc., Q2 2024 Earnings Call, Jul 31, 2024
07-31 Earnings Flash (VNDA) VANDA PHARMACEUTICALS Reports Q2 Revenue $50.5M, vs. Street Est of $47.9M MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
VANDA PHARMACEUTICALS INC. Stock Vanda Pharmaceuticals Inc.
291M - - -
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
126B
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
124B -
ARGENX SE Stock argenx SE
32.07B -
BIONTECH SE Stock BioNTech SE
24.97B -
BEIGENE, LTD. Stock BeiGene, Ltd.
20.85B -
  1. Stock Market
  2. Equities
  3. VNDA Stock
  4. Charts Vanda Pharmaceuticals Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW
United States

MarketScreener is also available in this country: United States.

Switch edition
Stay in the current country edition